The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Open accessAbstract
BACKGROUND: Noroviruses cause epidemic and sporadic acute gastroenteritis. No vaccine is available to prevent norovirus illness or infection. METHODS: We conducted a randomized, double-blind, placebo-controlled, multicenter trial to assess the safety, immunogenicity, and efficacy of an investigational, intranasally delivered norovirus viruslike particle (VLP) vaccine (with chitosan and monophosphoryl lipid A as adjuvants) to prevent acute viral gastroenteritis after challenge with a homologous viral strain, Norwalk virus (genotype GI.1). Healthy adults 18 to 50 years of age received two doses of either vaccine or placebo and were subsequently inoculated with Norwalk virus and monitored for infection and gastroenteritis symptoms. RESULTS: Ninety-eight persons were enrolled and randomly assigned to receive vaccine (50 participants) or placebo (48 participants), and 90 received both doses (47 participants in the vaccine group and 43 in the placebo group). The most commonly reported symptoms after vaccination were nasal stuffiness, nasal discharge, and sneezing. Adverse events occurred with similar frequency among vaccine and placebo recipients. A Norwalk virus-specific IgA seroresponse (defined as an increase by a factor of 4 in serum antibody levels) was detected in 70% of vaccine recipients. Seventy-seven of 84 participants inoculated with Norwalk virus were included in the per-protocol analysis. Vaccination significantly reduced the frequencies of Norwalk virus gastroenteritis (occurring in 69% of placebo recipients vs. 37% of vaccine recipients, P=0.006) and Norwalk virus infection (82% of placebo recipients vs. 61% of vaccine recipients, P=0.05). CONCLUSIONS: This norovirus VLP vaccine provides protection against illness and infection after challenge with a homologous virus. (Funded by LigoCyte Pharmaceuticals and the National Institutes of Health; ClinicalTrials.gov number, NCT00973284.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Human susceptibility and resistance to Norwalk virus infection
Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., & Baric, R. (2003) · Nature Medicine · doi:10.1038/nm860 · Cited by 1,119
Glass, R. I., Parashar, U. D., & Estes, M. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804575 · Cited by 1,010
Self-citationSystematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis
Patel, M. M., Widdowson, M.-A., Glass, R. I., Akazawa, K., Vinjé, J., & Parashar, U. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.071114 · Cited by 953
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
Jiang, X., Wang, M., Graham, D. Y., & Estes, M. K. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6527-6532.1992 · Cited by 860
Self-citationGenogroup-specific PCR primers for detection of Norwalk-like viruses
Kojima, S., Kageyama, T., Fukushi, S., Hoshino, F. B., Shinohara, M., Uchida, K., Natori, K., Takeda, N., & Katayama, K. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00404-9 · Cited by 813
Norwalk Virus Shedding after Experimental Human Infection
Atmar, R. L., Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., & Graham, D. Y. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.080117 · Cited by 760
Self-citationRuuska, T., & Vesikari, T. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027046 · Cited by 714
Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group Type
Hutson, A. M., Atmar, R. L., Graham, D. Y., & Estes, M. K. (2002) · The Journal of Infectious Diseases · doi:10.1086/339883 · Cited by 487
Self-citationClinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent
Parrino, T. A., Schreiber, D. S., Trier, J. S., Kapikian, A. Z., & Blacklow, N. R. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707142970204 · Cited by 478
Norwalk Virus Infection of Volunteers: New Insights Based on Improved Assays
Graham, D. Y., Jiang, X., Tanaka, T., Opekun, A. R., Madore, H. P., & Estes, M. K. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.1.34 · Cited by 449
Self-citationEpochal Evolution of GGII.4 Norovirus Capsid Proteins from 1995 to 2006
Siebenga, J. J., Vennema, H., Renckens, B., de Bruin, E., van der Veer, B., Siezen, R. J., & Koopmans, M. (2007) · Journal of Virology · doi:10.1128/jvi.00674-07 · Cited by 389
Norovirus disease: changing epidemiology and host susceptibility factors
Hutson, A. M., Atmar, R. L., & Estes, M. K. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.04.005 · Cited by 314
Self-citationRapid Evolution of Pandemic Noroviruses of the GII.4 Lineage
Bull, R. A., Eden, J.-S., Rawlinson, W. D., & White, P. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000831 · Cited by 301
Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis
Reeck, A., Kavanagh, O., Estes, M. K., Opekun, A. R., Gilger, M. A., Graham, D. Y., & Atmar, R. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/656364 · Cited by 278
Self-citationImmunity and correlates of protection for rotavirus vaccines
Franco, M. A., Angel, J., & Greenberg, H. B. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.048 · Cited by 268
Norwalk Virus-Like Particle Hemagglutination by Binding to H Histo-Blood Group Antigens
Hutson, A. M., Atmar, R. L., Marcus, D. M., & Estes, M. K. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.405-415.2003 · Cited by 262
Self-citationTaking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., & Persing, D. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1129 · Cited by 256
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
Tacket, C. O., Sztein, M. B., Losonsky, G. A., Wasserman, S. S., & Estes, M. K. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00120-7 · Cited by 238
Self-citationRecombinant Norwalk virus–like particles given orally to volunteers: Phase I study
Ball, J. M., Graham, D. Y., Opekun, A. R., Gilger, M. A., Guerrero, R. A., & Estes, M. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70548-2 · Cited by 227
Self-citationEl‐Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657087 · Cited by 226
Self-citationNorovirus Gastroenteritis, Carbohydrate Receptors, and Animal Models
Tan, M., & Jiang, X. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000983 · Cited by 204
Joura, E. A., Kjaer, S. K., Wheeler, C. M., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 198
Norwalk virus infection associates with secretor status genotyped from sera
Hutson, A. M., Airaud, F., LePendu, J., Estes, M. K., & Atmar, R. L. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20423 · Cited by 172
Self-citationBall, J. M., Hardy, M. E., Atmar, R. L., Conner, M. E., & Estes, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1345-1353.1998 · Cited by 160
Self-citationHeterotypic Humoral and Cellular Immune Responses following Norwalk Virus Infection
Lindesmith, L. C., Donaldson, E., León, J. S., Moe, C. L., Frelinger, J. A., Johnston, R. E., Weber, D. J., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02179-09 · Cited by 157
TLR signaling at the intestinal epithelial interface
Abreu, M. T., Thomas, L. S., Arnold, E. T., Lukasek, K., Michelsen, K. S., & Arditi, M. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103225002593 · Cited by 109
Guyader, F. S. L., Kröl, J., Ambert‐Balay, K., Ruvoën‐Clouet, N., Desaubliaux, B., Parnaudeau, S., Saux, J. L., Ponge, A., Pothier, P., Atmar, R. L., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01664-09 · Cited by 91
Self-citationMolecular Virology and the Epidemiology of Influenza
(1983) · The Lancet · doi:10.1016/s0140-6736(83)90518-4 · Cited by 67
Genetic Analysis of the Capsid Gene of Genotype GII.2 Noroviruses
Iritani, N., Vennema, H., Siebenga, J. J., Siezen, R. J., Renckens, B., Seto, Y., Kaida, A., & Koopmans, M. (2008) · Journal of Virology · doi:10.1128/jvi.02371-07 · Cited by 33
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Replication of human noroviruses in stem cell–derived human enteroids
Ettayebi, K., Crawford, S. E., Murakami, K., Broughman, J. R., Karandikar, U., Tenge, V. R., Neill, F. H., Blutt, S. E., Zeng, X.-L., Qu, L., et al. (2016) · Science · doi:10.1126/science.aaf5211 · Cited by 1,305
Self-citationNooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
Norovirus and Medically Attended Gastroenteritis in U.S. Children
Payne, D. C., Vinjé, J., Szilagyi, P. G., Edwards, K. M., Staat, M. A., Weinberg, G. A., Hall, C. B., Chappell, J., Bernstein, D. I., Curns, A. T., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1206589 · Cited by 610
Self-citationRobilotti, E., Deresinski, S., & Pinsky, B. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00075-14 · Cited by 589
Metadata
- Authors
- Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., & Mendelman, P. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-12-08
- Volume
- 365
- Issue
- 23
- Pages
- 2178-2187
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2025733005
- Cited by
- 490
- References
- 32
- FWCI
- 30.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.